Published in Fam Cancer on November 19, 2016
Clinical implications of the p53 tumor-suppressor gene. N Engl J Med (1993) 7.29
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A (2010) 5.60
Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med (2015) 4.77
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med (2007) 4.25
Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med (2007) 2.37
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol (2011) 1.85
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. J Clin Oncol (2015) 1.82
Breast cancer in Arab populations: molecular characteristics and disease management implications. Lancet Oncol (2013) 1.81
Inherited p53 gene mutations in breast cancer. Cancer Res (1992) 1.64
To die or not to die: how does p53 decide? Oncogene (2004) 1.45
Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene (1999) 1.26
Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med (2013) 1.25
Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg (2004) 1.03
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol) (2007) 0.96
A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer (2007) 0.94
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Mol Cancer Res (2011) 0.89
The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet (1998) 0.88
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer (2010) 0.86
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat (2010) 0.86
BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist (2015) 0.83
Two BRCA1/2 founder mutations in Jews of Sephardic origin. Fam Cancer (2011) 0.76
Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation. Genet Mol Biol (2016) 0.75
Genetic features of Lynch syndrome in the Israeli population. Clin Genet (2014) 0.75
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Res Treat (2015) 0.75